SkinHealth Systems (SKIN) Common Equity (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Common Equity data on file, last reported at $55.2 million in Q1 2026.

• Common Equity for Q1 2026 came in at $55.2 million, up 19.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.2 million (up 19.93% YoY), and the FY2025 annual result was $61.1 million, up 17.86% from the prior year.
• Common Equity declined to $55.2 million in Q1 2026 per SKIN's latest filing, from $61.1 million in the prior quarter.
• Over five years, Common Equity peaked at $345.4 million in Q2 2022 and troughed at $46.1 million in Q1 2025.
• A 5-year average of $124.1 million and a median of $69.2 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2023: Common Equity jumped 2049.35% in 2022, then tumbled 64.45% in 2023.
• A 5-year view of Common Equity shows it stood at $167.1 million in 2022, then plunged by 64.45% to $59.4 million in 2023, then declined by 12.77% to $51.8 million in 2024, then climbed by 17.86% to $61.1 million in 2025, then slipped by 9.53% to $55.2 million in 2026.
• Business Quant data shows SKIN's Common Equity at $55.2 million in Q1 2026, $61.1 million in Q4 2025, and $65.7 million in Q3 2025.